CD4 and neoplasm: The described killing effect was achieved with only two injections of CpG+OVA+PTX+CQ-N/A and resulted in the downregulation of PD-L1 in T cells and the induction of CD8+ and CD4+ T cell generation, which are probably the main effector cells for tumor regression and recurrence.